Cigna Investments Inc. New lowered its position in The Procter & Gamble Company (NYSE:PG – Free Report) by 0.9% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 24,086 shares of the company’s stock after selling 214 shares during the period. Procter & Gamble makes up about 0.7% of Cigna Investments Inc. New’s portfolio, making the stock its 20th largest position. Cigna Investments Inc. New’s holdings in Procter & Gamble were worth $4,038,000 at the end of the most recent reporting period.
A number of other institutional investors also recently bought and sold shares of PG. RPg Family Wealth Advisory LLC purchased a new stake in shares of Procter & Gamble during the third quarter worth $33,000. Bay Harbor Wealth Management LLC increased its stake in Procter & Gamble by 972.0% in the fourth quarter. Bay Harbor Wealth Management LLC now owns 268 shares of the company’s stock valued at $45,000 after purchasing an additional 243 shares during the last quarter. New Wave Wealth Advisors LLC purchased a new position in Procter & Gamble in the fourth quarter valued at approximately $46,000. Costello Asset Management INC increased its stake in Procter & Gamble by 2,142.9% in the third quarter. Costello Asset Management INC now owns 314 shares of the company’s stock valued at $54,000 after purchasing an additional 300 shares during the last quarter. Finally, DecisionPoint Financial LLC grew its position in shares of Procter & Gamble by 46.7% during the fourth quarter. DecisionPoint Financial LLC now owns 330 shares of the company’s stock worth $55,000 after acquiring an additional 105 shares during the last quarter. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Trading Down 0.3 %
NYSE:PG opened at $167.45 on Tuesday. The company has a current ratio of 0.76, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The stock has a market capitalization of $392.64 billion, a PE ratio of 26.66, a price-to-earnings-growth ratio of 3.79 and a beta of 0.45. The firm’s 50 day moving average is $167.30 and its 200 day moving average is $169.43. The Procter & Gamble Company has a 12 month low of $153.52 and a 12 month high of $180.43.
Procter & Gamble Announces Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, February 18th. Shareholders of record on Friday, January 24th will be paid a dividend of $1.0065 per share. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.40%. The ex-dividend date of this dividend is Friday, January 24th. Procter & Gamble’s dividend payout ratio is 64.17%.
Insider Buying and Selling at Procter & Gamble
In other news, insider Marc S. Pritchard sold 90,450 shares of Procter & Gamble stock in a transaction on Thursday, January 23rd. The shares were sold at an average price of $163.84, for a total transaction of $14,819,328.00. Following the transaction, the insider now owns 172,814 shares in the company, valued at $28,313,845.76. This trade represents a 34.36 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CEO Gary A. Coombe sold 47,847 shares of the stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $179.84, for a total transaction of $8,604,804.48. Following the transaction, the chief executive officer now directly owns 39,977 shares of the company’s stock, valued at $7,189,463.68. This trade represents a 54.48 % decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 151,097 shares of company stock valued at $25,635,076. Corporate insiders own 0.18% of the company’s stock.
Wall Street Analyst Weigh In
A number of equities research analysts have commented on the company. Barclays raised their target price on Procter & Gamble from $155.00 to $159.00 and gave the company an “equal weight” rating in a report on Thursday, January 23rd. Wells Fargo & Company boosted their price target on Procter & Gamble from $176.00 to $180.00 and gave the stock an “overweight” rating in a research report on Thursday, January 23rd. JPMorgan Chase & Co. lowered their price target on Procter & Gamble from $186.00 to $181.00 and set an “overweight” rating for the company in a report on Thursday, January 16th. DA Davidson reiterated a “buy” rating and set a $209.00 price target on shares of Procter & Gamble in a research report on Thursday, January 23rd. Finally, Stifel Nicolaus upped their target price on Procter & Gamble from $161.00 to $165.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Eight equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have given a strong buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $180.53.
View Our Latest Stock Analysis on PG
Procter & Gamble Company Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- How to Invest in Insurance Companies: A Guide
- Monday.com Stock Could Soar to New Highs—Here’s How
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Merck: 4 No-Brainer Reasons to Buy This Dip
- Why Invest in 5G? How to Invest in 5G Stocks
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.